Biotech Values

[bladerunner1717]

Re: “Cash-rich” biotechs (no thanks)

In recent years, I’ve passed on investing in biotechs primarily (or solely) for their cash.

Dew,

I was in NO WAY implying that these stocks should be considered primarily or solely for their cash. The point here is that there MIGHT be value in the pipeline that is not being reflected in the share price.

DMTX is a very recent case in point.

ADVM is a favorite of Ohad Hammer, not exactly an off-the-wall biotech investor.

Whatever happened to "Wallstarb?" I miss him.


Bladerunner